Beclin1 haploinsufficiency compromises mesenchymal stem cell-offered cardioprotection against myocardial infarction

Abstract Mesenchymal stem cells (MSCs)-based therapy has displayed some promises in ischemia heart diseases although its efficacy may be affected by changes in surrounding environments. This study evaluated the role of autophagy insufficiency using Beclin1 haploinsufficiency (BECN+/−) on intra-myoca...

Full description

Bibliographic Details
Main Authors: Xing Qin, Juanjuan Fei, Yu Duan, Asli F. Ceylan, Fuyang Zhang, Jun Ren
Format: Article
Language:English
Published: SpringerOpen 2022-06-01
Series:Cell Regeneration
Subjects:
Online Access:https://doi.org/10.1186/s13619-022-00121-y
_version_ 1828820861193289728
author Xing Qin
Juanjuan Fei
Yu Duan
Asli F. Ceylan
Fuyang Zhang
Jun Ren
author_facet Xing Qin
Juanjuan Fei
Yu Duan
Asli F. Ceylan
Fuyang Zhang
Jun Ren
author_sort Xing Qin
collection DOAJ
description Abstract Mesenchymal stem cells (MSCs)-based therapy has displayed some promises in ischemia heart diseases although its efficacy may be affected by changes in surrounding environments. This study evaluated the role of autophagy insufficiency using Beclin1 haploinsufficiency (BECN+/−) on intra-myocardial MSC transplantation-evoked effect against myocardial infarction. Donor MSCs from C57BL/6 mice were labelled with cell-tracker CM Dil and were delivered into LV free wall adjacent to infarct region in wild-type (WT) and BECN+/− recipient mice following ligation of left main coronary artery (MI-MSCs). Ten days following MI, myocardial function was assessed using echocardiography. Cardiomyocyte contractility and intracellular Ca2+ were monitored using cardiomyocytes from the area-at-risk adjacent to infarct. CM-Dil labeled cells were tracked in MSCs recipient mice using fluorescence microscopy. Lectin, Masson trichrome staining and Western blot analysis were employed to determine cardiomyocyte area, scar fibrosis, apoptosis and inflammation. MI insult triggered scar fibrosis, LV chamber dilation, decreased fractional shortening, ejection fraction, cardiomyocyte shortening, maximal velocity of shortening and relengthening as well as prolonged relengthening, which were abrogated or attenuated by MSCs therapy in WT but not BECN+/− mice. MI decreased intracellular Ca2+ rise and decay in response to electrical stimuli without affecting resting intracellular Ca2+, which were reconciled by MSCs in WT but not BECN+/− mice. MSCs further attenuated MI-induced mitochondrial ultrastructural injury, apoptosis, inflammation and autophagy defects in peri-infarct area in WT but not BECN+/− mice. Collectively, our results suggested that autophagy insufficiency dampened in MSCs-elicited cardioprotection associated with dampened apoptosis and inflammation.
first_indexed 2024-12-12T12:41:28Z
format Article
id doaj.art-30ab90ef8e4f412a8c9dccf191d0ad6e
institution Directory Open Access Journal
issn 2045-9769
language English
last_indexed 2024-12-12T12:41:28Z
publishDate 2022-06-01
publisher SpringerOpen
record_format Article
series Cell Regeneration
spelling doaj.art-30ab90ef8e4f412a8c9dccf191d0ad6e2022-12-22T00:24:12ZengSpringerOpenCell Regeneration2045-97692022-06-0111111110.1186/s13619-022-00121-yBeclin1 haploinsufficiency compromises mesenchymal stem cell-offered cardioprotection against myocardial infarctionXing Qin0Juanjuan Fei1Yu Duan2Asli F. Ceylan3Fuyang Zhang4Jun Ren5Department of Cardiology, Xijing Hospital, Fourth Military Medical UniversityDepartment of Cardiology and Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital Fudan UniversityDepartment of Cardiology, Xijing Hospital, Fourth Military Medical UniversityDepartment of Medical Pharmacology, Ankara Yildirim Beyazit University, Faculty of MedicineDepartment of Cardiology, Xijing Hospital, Fourth Military Medical UniversityDepartment of Cardiology and Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital Fudan UniversityAbstract Mesenchymal stem cells (MSCs)-based therapy has displayed some promises in ischemia heart diseases although its efficacy may be affected by changes in surrounding environments. This study evaluated the role of autophagy insufficiency using Beclin1 haploinsufficiency (BECN+/−) on intra-myocardial MSC transplantation-evoked effect against myocardial infarction. Donor MSCs from C57BL/6 mice were labelled with cell-tracker CM Dil and were delivered into LV free wall adjacent to infarct region in wild-type (WT) and BECN+/− recipient mice following ligation of left main coronary artery (MI-MSCs). Ten days following MI, myocardial function was assessed using echocardiography. Cardiomyocyte contractility and intracellular Ca2+ were monitored using cardiomyocytes from the area-at-risk adjacent to infarct. CM-Dil labeled cells were tracked in MSCs recipient mice using fluorescence microscopy. Lectin, Masson trichrome staining and Western blot analysis were employed to determine cardiomyocyte area, scar fibrosis, apoptosis and inflammation. MI insult triggered scar fibrosis, LV chamber dilation, decreased fractional shortening, ejection fraction, cardiomyocyte shortening, maximal velocity of shortening and relengthening as well as prolonged relengthening, which were abrogated or attenuated by MSCs therapy in WT but not BECN+/− mice. MI decreased intracellular Ca2+ rise and decay in response to electrical stimuli without affecting resting intracellular Ca2+, which were reconciled by MSCs in WT but not BECN+/− mice. MSCs further attenuated MI-induced mitochondrial ultrastructural injury, apoptosis, inflammation and autophagy defects in peri-infarct area in WT but not BECN+/− mice. Collectively, our results suggested that autophagy insufficiency dampened in MSCs-elicited cardioprotection associated with dampened apoptosis and inflammation.https://doi.org/10.1186/s13619-022-00121-yMyocardial infarctionMSCsBeclin1ContractionApoptosisAutophagy
spellingShingle Xing Qin
Juanjuan Fei
Yu Duan
Asli F. Ceylan
Fuyang Zhang
Jun Ren
Beclin1 haploinsufficiency compromises mesenchymal stem cell-offered cardioprotection against myocardial infarction
Cell Regeneration
Myocardial infarction
MSCs
Beclin1
Contraction
Apoptosis
Autophagy
title Beclin1 haploinsufficiency compromises mesenchymal stem cell-offered cardioprotection against myocardial infarction
title_full Beclin1 haploinsufficiency compromises mesenchymal stem cell-offered cardioprotection against myocardial infarction
title_fullStr Beclin1 haploinsufficiency compromises mesenchymal stem cell-offered cardioprotection against myocardial infarction
title_full_unstemmed Beclin1 haploinsufficiency compromises mesenchymal stem cell-offered cardioprotection against myocardial infarction
title_short Beclin1 haploinsufficiency compromises mesenchymal stem cell-offered cardioprotection against myocardial infarction
title_sort beclin1 haploinsufficiency compromises mesenchymal stem cell offered cardioprotection against myocardial infarction
topic Myocardial infarction
MSCs
Beclin1
Contraction
Apoptosis
Autophagy
url https://doi.org/10.1186/s13619-022-00121-y
work_keys_str_mv AT xingqin beclin1haploinsufficiencycompromisesmesenchymalstemcellofferedcardioprotectionagainstmyocardialinfarction
AT juanjuanfei beclin1haploinsufficiencycompromisesmesenchymalstemcellofferedcardioprotectionagainstmyocardialinfarction
AT yuduan beclin1haploinsufficiencycompromisesmesenchymalstemcellofferedcardioprotectionagainstmyocardialinfarction
AT aslifceylan beclin1haploinsufficiencycompromisesmesenchymalstemcellofferedcardioprotectionagainstmyocardialinfarction
AT fuyangzhang beclin1haploinsufficiencycompromisesmesenchymalstemcellofferedcardioprotectionagainstmyocardialinfarction
AT junren beclin1haploinsufficiencycompromisesmesenchymalstemcellofferedcardioprotectionagainstmyocardialinfarction